Mohammad Yousef Memar

4.1k total citations · 2 hit papers
118 papers, 3.0k citations indexed

About

Mohammad Yousef Memar is a scholar working on Molecular Medicine, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Mohammad Yousef Memar has authored 118 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Medicine, 37 papers in Molecular Biology and 20 papers in Infectious Diseases. Recurrent topics in Mohammad Yousef Memar's work include Antibiotic Resistance in Bacteria (30 papers), Bacterial Identification and Susceptibility Testing (18 papers) and Bacterial biofilms and quorum sensing (15 papers). Mohammad Yousef Memar is often cited by papers focused on Antibiotic Resistance in Bacteria (30 papers), Bacterial Identification and Susceptibility Testing (18 papers) and Bacterial biofilms and quorum sensing (15 papers). Mohammad Yousef Memar collaborates with scholars based in Iran, United States and Azerbaijan. Mohammad Yousef Memar's co-authors include Naser Alizadeh, Reza Ghotaslou, Mina Yekani, Hossein Bannazadeh Baghi, Hossein Samadi Kafil, Simin Sharifi, Solmaz Maleki Dizaj, Khosro Adibkia, Sepideh Zununi Vahed and Seyed Mahdi Hosseiniyan Khatibi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and ACS Applied Materials & Interfaces.

In The Last Decade

Mohammad Yousef Memar

110 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Paxlovid (Nirmatrelvir/Ritonavir): A new approach to Covid-19 therapy?

2023 88 citations Mohammad Yousef Memar, Hossein Bannazadeh Baghi et al. Biomedicine & Pharmacotherapy profile →
Antimicrobial activity of nanoformulations of carvacrol and thymol: New trend and applications

2023 73 citations Mina Yekani, Simin Sharifi et al. OpenNano profile →

Peers

Countries citing papers authored by Mohammad Yousef Memar

Since Specialization

Citations

This map shows the geographic impact of Mohammad Yousef Memar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Yousef Memar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Yousef Memar more than expected).

Fields of papers citing papers by Mohammad Yousef Memar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammad Yousef Memar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Yousef Memar. The network helps show where Mohammad Yousef Memar may publish in the future.

Co-authorship network of co-authors of Mohammad Yousef Memar

This figure shows the co-authorship network connecting the top 25 collaborators of Mohammad Yousef Memar. A scholar is included among the top collaborators of Mohammad Yousef Memar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammad Yousef Memar. Mohammad Yousef Memar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical Assessment of the Effect of Hypericum perforatum Chewing Gum on Salivary Streptococcus mutans Count, pH, Plaque Index, and Gingival Bleeding: A Randomized Clinical Trial 2026 ·Clinical and Experimental Dental Research ·(unknown), (unknown), Mohammad Yousef Memar, (unknown), Maryam Kouhsoltani, (unknown)	0
2	Antibacterial potential of rutin nanoformulations: Current insights and future directions 2026 ·Biomedicine & Pharmacotherapy ·(unknown), (unknown), (unknown), Elham Ahmadian, (unknown), Mohammad Yousef Memar, (unknown), (unknown)	0
3	Antibacterial Activity of Curcumin-loaded Mesoporous Silica Nanoparticles against Streptococcus mutans 2025 ·The Open Dentistry Journal ·Mohammad Yousef Memar, (unknown), Simin Sharifi, Solmaz Maleki Dizaj	1
4	MicroRNAs and human viral diseases: A focus on the role of microRNA-29 2024 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Mina Mobini Kesheh, (unknown), (unknown), (unknown), (unknown), Mohammad Yousef Memar, Hossein Bannazadeh Baghi, (unknown), (unknown), (unknown), (unknown), Javid Sadri Nahand, Seyed Mohammadreza Hashemian, Hamed Mirzaei	10
5	*Modern In Silico* Molecular Docking Perspective for Investigation of Rindera lanata Bunge var. lanata targeting: Phytochemical Profile, Phytotoxicity and Bioactivity Assays** 2024 ·Pharmaceutical Sciences ·(unknown), Sanaz Hamedeyazdan, (unknown), Mostafa Alilou, Abbas Delazar, Samad Nejad Ebrahimi, (unknown), Mohammad Yousef Memar, Hossein Nazemiyeh	1
6	Chitosan-Alginate Hydrogel Enriched with Hypericum perforatum Callus Extract for Improved Wound Healing and Scar Inhibition 2024 ·ACS Applied Materials & Interfaces ·(unknown), (unknown), Behrooz Shokouhi, Morteza Kosari‐Nasab, Mohammad Reza Farahpour, Mohammad Yousef Memar, Soodabeh Davaran, Jalal Hanaee, Mohammad‐Reza Rashidi, Mehdi Mehrali	9
7	Hepcidin: A potent antimicrobial peptide involved in iron homeostasis 2024 ·Gene Reports ·Saiedeh Razi Soofiyani, (unknown), (unknown), (unknown), Mohammad Yousef Memar	1
8	Preparation, biocompatibility, and antimicrobial effects of gelatin nanofibers scaffolds containing vancomycin and curcumin 2023 ·Journal of Drug Delivery Science and Technology ·Mina Yekani, Solmaz Maleki Dizaj, Hossein Sedaghat, Javid Sadri Nahand, Mahmood Saffari, Mohammad Yousef Memar	10
9	Cytotoxicity and biocompatibility of Meropenem-loaded graphene oxide and its antibacterial effects against carbapenem-resistant Gram-negative bacteria 2023 ·OpenNano ·Mohammad Yousef Memar, Yalda Rahbar Saadat, Solmaz Maleki Dizaj, Mina Yekani, (unknown), (unknown), Sepideh Zununi Vahed, Simin Sharifi	5
10	Short‐chain fatty acids profile in patients with SARS‐CoV‐2: A case‐control study 2023 ·Health Science Reports ·Edris Nabizadeh, Mohammad Yousef Memar, Hamed Hamishehkar, (unknown), (unknown), Solmaz Asnaashari, Hossein Samadi Kafil, Mojtaba Varshochi, Mostafa Mostafazadeh, (unknown), Reza Ghotaslou	5
11	The Antibacterial Effect of Ciprofloxacin Loaded Calcium Carbonate (CaCO3) Nanoparticles Against the Common Bacterial Agents of Osteomyelitis 2023 ·Current Microbiology ·Mohammad Yousef Memar, Mohammad Ahangarzadeh Rezaee, Mohammad Barzegar-Jalali, Tooba Gholikhani, Khosro Adibkia	8
12	In vitro Antibacterial Effects of Curcumin-loaded Mesoporous Silica Nanoparticles inside the Dental Implant Fixture 2023 ·The Open Dentistry Journal ·Adileh Shirmohammadi, (unknown), Ramin Negahdari, Solmaz Maleki Dizaj, Mohammad Yousef Memar	2
13	Preparation and Evaluation of Chitosan Nanoparticles containing Iranian Eschium Amoenum Extract and its Antimicrobial Effects on Common Oral Microorganisms 2023 ·The Open Dentistry Journal ·Farshad Barzegar, Sepideh Bohlouli, (unknown), Solmaz Maleki Dizaj, Mohammad Yousef Memar, (unknown)	0
14	Antibacterial and Biofilm Inhibitory Effects of Rutin Nanocrystals 2022 ·Biointerface Research in Applied Chemistry ·Mohammad Yousef Memar, Mina Yekani, Simin Sharifi, Solmaz Maleki Dizaj, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	23
15	Contribution of Arginine Catabolic Mobile Element and Copper and Mercury Resistance Element in Methicillin-Resistant Staphylococcus aureus: A Vantage Point 2022 ·Canadian Journal of Infectious Diseases and Medical Microbiology ·(unknown), Alka Hasani, Mohammad Aghazadeh, Mohammad Yousef Memar, Akbar Hasani, (unknown), Mohammad Ahangarzadeh Rezaee, Javid Sadeghi	4
16	The Effect of Oncogene Proteins of Human Papillomaviruses on Apoptosis Pathways in Prostate Cancer 2022 ·ONCOLOGIE ·(unknown), Mohammad Yousef Memar, Abolfazl Jafari-Sales, Ahad Bazmani, Javid Sadri Nahand, Parisa Shiri Aghbash, Hossein Bannazadeh Baghi	15
17	Targeted therapy in Coronavirus disease 2019 (COVID-19): Implication from cell and gene therapy to immunotherapy and vaccine 2022 ·International Immunopharmacology ·Moein Shirzad, (unknown), (unknown), Maryam Ranjbar, (unknown), (unknown), (unknown), Seyed Mostafa Mir, Mohammad Yousef Memar	10
18	Antibacterial and Antibiofilm Activity of Grape Seed Extract Against Carbapenem Resistant and Biofilm Producer Enterobacteriaceae 2018 ·SHILAP Revista de lepidopterología ·(unknown), Abbas Delazar, Mohammad Yousef Memar, Reza Ghotaslou	2
19	The Presence of Porphyromonas Gingivalis, Chlamydia Pneumonia, Helicobacter Pylori, Mycoplasma Pneumonia and Enterobacter Hormaechei DNA in the Atherosclerotic Plaques 2018 ·Journal of Research in Medical and Dental Science ·(unknown), Hossein Bannazadeh Baghi, Mohammad Yousef Memar, (unknown), (unknown), (unknown), Naser Alizadeh, Reza Ghotaslou	2
20	Class D OXA-48 carbapenemase in Escherichia coli and Klebsiella pneumoniae: an emerging threat to burn patients. 2014 ·Journal of Pure and Applied Microbiology ·Mohammad Taghi Akhi, Mohammad Reza Nahaei, (unknown), (unknown), Tahereh Pirzadeh, Mohammad Yousef Memar, Babak Asghari	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact